Company

Sierra Oncology, Inc. (0001290149)

Standardized SEC financial data for Sierra Oncology, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001290149 · Pharmaceutical Preparations.

Return on equity

-98.6%

Free cash flow

-$79.0M

Current ratio

8.34×

Ratios for fiscal year 2020, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Revenue	—	—	—	—	$300K	—
R&D expense	$33.9M	$30.2M	$41.1M	$53.2M	$45.1M	$67.2M
SG&A expense	$14.2M	$12.5M	$14.3M	$13.7M	$20.1M	$27.4M
Operating income	-$48.1M	-$42.6M

Standardized from Sierra Oncology, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Cash & equivalents	$109.2M	$100.5M	$106.3M	$147.8M	$104.4M	$105.0M
Total current assets	$110.3M	$101.7M	$108.8M	$149.9M	$106.5M	$107.4M
Property, plant & equipment	$400K	$154K	$168K	$113K

Cash flow

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Operating cash flow	-$41.2M	-$36.2M	-$45.1M	-$51.2M	-$52.4M	-$79.0M
Capital expenditures	$214K	$92K	$118K	$39K	$12K	$72K
Free cash flow	-$41.4M	-$36.3M	-$45.2M	-$51.2M

Get 0001290149 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001290149/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001290149/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001290149 filings on SEC EDGAR →